VANCOUVER, BC, Oct. 13, 2022 /PRNewswire/ Recent study report released by Data Bridge Market research titled "Lower Back Pain Market" guarantees one will remain better informed than the competition.
There was a strong, but not statistically significant, signal of reduced spinal structural damage with the combination of a selective COX-2 inhibitor and a TNF inhibitor in axial spondyloarthritis.
/PRNewswire/ According to Coherent Market Insights, the global osteoarthritis drugs market is estimated to be valued at US$ 8,592.2 million in 2022 and is.